, mean body mass index(BMI) was 26. 99±4.23(18,31-40,00) and mean years since menopause was 8. 90±7.20(1,00-50,00) 
INTRODUCTION
Menopause is a physiological phenomenon in the normal aging process that emerges with the cessation of ovarian functions and reveals itself with the stopping of monthly cycles. In menopause period, follicle development and cyclic estrogen secreting stops with the decrease of ovarian follicles responding to gonadotropins (1, 2) .
After approximately 35, there is anovulation, luteal phase abnormalities and and slight increase in FSH in most people (3) . It is possible that these hormonal changes affect the remodeling of the bones and significant bone loss occurs in some cases even before menopause (4) .
In most cases, testosterone hormone decreases at the ratio of 25-50% in menopause (5) . In postmenopausal cases, first resource of testosterone is the androgens that are formed by transformation from dehydroepiandrosterone (DHEA). DHEA is also aromatized to estrone by transforming into androstenedion. Estrones formed this way in the adipose tissue are the main estrogens in the postmenopausal cases. Androstenedion decrease at the ratio of 50% with menopause (6) . Androstenedion and testosterone have a daily rhythm. Adrenal glands play an important role in testosterone formation. With menopause; DHEA and DHEA sulfate (DHEAS) decrease 60% and 80%, respectively. About 15% of these hormones are ovary based in the reproduction periods (1, 7) .
While the most significant change in early postmenopausal period is inadequacy in estrogen hormones; adequate secretion of other steroids, androgens in particular, is important for the bones in future periods (8) .
Mechanism of the changes that ovary secretion inadequacy causes in the bones during menopause is complicated. Remodeling on the endosteal surface of trabecular and cortical bone, increase in bone turnover frequency are the well-known mechanisms (9) . Unless there is an imbalance between the increase in bone cycle frequency and construction-breakdown, a singly ongoing bone mass loss doesn't occur. It is known that breakdown increases in the inadequacy of estrogen (10) .
Increase of the activation frequency raises the possibility of breakdown cavity formation on both surfaces of one trabecula at the same time and causes fracture in trabeculas with the combination of these cavities moving on from different sides and consequently leads to microstructural disruption (11) . Androgens have a direct anabolic effect on the bone via androgen receptors (12) . It is thought that androgens cause this effect by increasing the production of growing factors like local estrogen and insulin (13, 14) .
In this study, we aimed to investigate the relationship between mineral density of femur neck-lumbar vertebral No statistically significant correlation was determined among the other parameters (Table II) . In the multiple regression analysis, when lumbar vertebral T score was taken as the dependent variable; it was monitored that BMI (p=0,028; ß=0,131) and menopause time (p=0,048; ß=-0,149) affected the lumbar vertebral T score independently. Independent relation between FAI, DHEAS, patients' ages and lumbar vertebral T score wasn't determined (Table III) .
When femur neck T score was taken as the dependent variable; it was determined that TTE (p=0,001; ß=-0,267), SHBG (p=0,001; ß=-0,149) and free androgen index (p=0,005; ß=0,407) affected the femur neck T score independently. But, independent relation between DHEAS, VKI and femur neck T score wasn't monitored (Table IV) . 
DISCUSSION
Bone turnover increases secondary to the estrogen inadequacy that develops after menopause. Fast bone loss may also cause osteoporosis. Both patient's peak bone mass and bone loss after menopause are effective on osteoporosis formation. It has been stated that decrease in bone density occurs together with increase in bone resorption during postmenopausal period (15) .
In the studies conducted, results in which a relation between BMD and endogen E2 levels was determined (16, 17) and not determined (18, 19) were obtained.
Greendale et al. carried out a study based on a large population of old women living in the society and as a result determined significant correlation between both total and bioactive E2 level, and bone mineral density in all the areas (20) . On the contrary, Yoshimura et al. concluded that serum E2 level doesn't significantly affect the bone loss amount in postmenopausal women (4) .
In our study, no statistically significant relation and correlation was determined between endogen E2 levels and BMD or both lumbar vertebral and femur neck T score. The facts that our study was conducted in a single center and included a specific patient population may suggest the genetic reasons affecting BMD in terms of peak bone mass.
It is known that androgens have anabolic effects on bones. Experimental studies have shown that testosterone that functions through androgen receptors has direct or estrogen-independent effects on the bone cells (21) . Studies conducted among premenopausal women with hyperandrogen have shown that these women have higher bone mineral density and there is a positive relationship between serum testosterone levels and femur neck and lumbar vertebra bone mineral density (22) . Effects of endogen androgens on BMD in postmenopausal women are less known.
In our study, an independent relation between femur neck T score and TTE, SHBG levels and FAI was determined. Lambrinoudaki et al. showed the relation between femur neck T score and TTE, FAI in their study among 884 postmenopausal healthy Greek women (23) .
Also, in their 10 years prospective study conducted on 104 postmenopausal women, Wu et al. concluded that testosterone in circulation is a significant determinant of bone mineral density in various areas of the proximal femur (24) . On the contrary, in a cohort of postmenopausal women in another study, no relation was found between the bioactive testosterone and bone mineral density in lumbar vertebras and femur neck (25) .
Adrenal androgens are associated with postmenopausal bone loss. DHEAS is a major adrenal androgen and decreases in serum level along with aging both in women and men. Inadequacy of DHEAS is related with decrease in bone and muscle mass, increase in lipid mass and increased atherosclerosis risk and type-2 diabetes (26) .
In our study, correlation between serum levels of endogen DHEAS and lumbar vertebral and femur neck bone mineral density was determined in Pearson correlation. Findings we have obtained are in the same direction with the previous studies conducted among postmenopausal women showing that there is a relation between DHEAS and absolute bone mineral density and level of bone loss (27, 28) . On the contrary, there are also studies where no positive relation was determined between DHEAS and BMD (12, 23, 29) .
Effect of obesity on bone mineral density in postmenopausal osteoporosis has been subject to many studies until today. It is accepted that obesity has a positive effect on BMD in general. In our study, a significant correlation between BMI and both lumbar vertebral and femur neck T scores was determined, too. Although this is thought to be an expected result, in the recent studies it has been stated that BMI is not a good BMD indicator any more (30) . The fact that it is one of the most significant variables compared to other parameters in our study appears interesting.
When the menopause duration of the patients were compared, negative correlation was monitored in only lumbar vertebral T score. While significant decrease was determined in the menopause duration and both lumbar vertebral and femur neck T score in the previous studies (31, 32) , because the results were obtained crosssectionally and weren't compared to any initial value in our research, it was thought that only menopausal duration could be related with the decrease in lumbar vertebral BMD.
Postmenopausal serum sex steroid hormone levels are among the factors determining osteoporosis (33, 34) . As 
